The Market
A $25 billion opportunity — largely untapped
An estimated 40–80 million Americans suffer from chronic bad breath. The global bad breath treatment market stands at $14–15 billion today and is expected to exceed $25 billion by 2030.
40–80M
Americans with chronic bad breath
150–200M+
Cumulative U.S. market potential for TongueVǎge™
$2.5–$4.5B
Annual U.S. spend on bad breath products
$25B+
Global bad breath market projected by 2030
U.S. market
150–200 million potential consumers
An estimated 40–80 million Americans — roughly 12–25% of the population — suffer from chronic bad breath. A further 50–65% experience occasional bad breath, creating a cumulative potential market of 150–200+ million consumers for TongueVǎge™.
An estimated $2.5–$4.5 billion is spent annually in the U.S. on bad breath-related products — mostly on temporary masking solutions such as gum and mouthwash, not on solving the root cause (tongue biofilm). Only a tiny fraction of current spending is truly treatment-focused.
The Serviceable Obtainable Market includes end-users that could realistically be captured in the near term, based on distribution, competition, and execution capacity. The first 3–5 years of business could potentially generate tens of millions of dollars across retail, clinical sales, and direct-to-consumer channels.
Global market
From $14–15 billion today to $25 billion by 2030
At the global level, the bad breath treatment market is estimated at $14–15 billion today. The majority of that spend remains concentrated in temporary masking products — leaving the treatment-focused, root-cause segment dramatically underserved and positioned for outsized growth as consumer awareness and clinical positioning converge.
Global bad breath market
The vast majority of current spend is on temporary masking — not root-cause treatment.
Go-to-market
Three channels to market
Direct-to-consumer (DTC)
Online and subscription channels allow TongueVǎge™ to reach motivated consumers directly, with strong margins and the ability to build a loyal, recurring customer base.
Retail
Placement in pharmacy and specialty health retail channels brings TongueVǎge™ to the mass market — alongside the mouthwash and scraper products it is designed to replace.
Clinical sales
Dental offices and physician practices represent a high-trust distribution channel — where a doctor-recommended device carries the credibility premium consumers are already willing to pay for.